| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/23/2009 | US20090104116 Compounds for the inhibition of integrins and use thereof |
| 04/23/2009 | US20090102371 Fluoranthene derivative and organic light emitting device having the same |
| 04/23/2009 | US20090101890 Azaperylenes as organic semiconductors |
| 04/23/2009 | CA2703037A1 Organic compounds |
| 04/23/2009 | CA2702958A1 Method for producing pyrazole fused ring derivative |
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2702503A1 Cgrp-antagonists |
| 04/23/2009 | CA2702445A1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050747A1 Dimers of harmol or of its derivatives and uses thereof |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049538A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use |
| 04/22/2009 | EP2049537A1 1, 7-naphthyridine derivatives as p38 map kinase inhibitors |
| 04/22/2009 | EP2049536A2 Polycyclic viral inhibitors |
| 04/22/2009 | EP2049535A1 Alpha-carboline derivatives and methods for preparation thereof |
| 04/22/2009 | EP2049534A1 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
| 04/22/2009 | EP2049503A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 04/22/2009 | EP2049490A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl]-l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors |
| 04/22/2009 | EP2049483A2 Inhibitors of histone deacetylase |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2049110A2 Bridged diazepan orexin receptor antagonists |
| 04/22/2009 | EP1689391B1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones |
| 04/22/2009 | CN101415707A Heterobicyclic amide derivatives |
| 04/22/2009 | CN101415706A Azolopyridin-3-one derivatives as inhibitors of endothelial lipase |
| 04/22/2009 | CN101415705A Compounds and methods for inhibiting hepatitis c viral replication |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415701A Heterocyclylacrylamide compounds as FABI inhibitors and antibacterial agents |
| 04/22/2009 | CN101412721A 6,13-substituted pentacene and derivatives thereof, as well as preparation |
| 04/22/2009 | CN101412651A Pentacenes and derivatives thereof, as well as thereof |
| 04/22/2009 | CN100480249C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521557 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods |
| 04/21/2009 | US7521556 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521459 Method for treating damaged skin |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/16/2009 | WO2009047522A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | WO2009047506A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047336A1 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists |
| 04/16/2009 | WO2009047298A2 Dimers of harmol or of its derivatives and uses thereof |
| 04/16/2009 | WO2009047255A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009000832A3 Chemical compounds |
| 04/16/2009 | WO2008124571A3 Anti-viral compounds, compositions and methods |
| 04/16/2009 | WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 04/16/2009 | WO2008047952A3 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/16/2009 | WO2007022529A3 Method of treating inflammatory diseases |
| 04/16/2009 | WO2006104917A3 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| 04/16/2009 | US20090099228 insomnia or eating disorders such as anorexia; 2-{1-Ethyl-4-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-3-methyl-1,4,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-5-yl}-N-methyl-2-phenyl-acetamide for example |
| 04/16/2009 | US20090099226 Quinoline derivatives as ep4 antagonists |
| 04/16/2009 | US20090099222 Modulators of muscarinic receptors |
| 04/16/2009 | US20090099176 Pyrrolopyridine-2-carboxylic acid amides |
| 04/16/2009 | US20090099175 Phosphodiesterase 10 inhibitors |
| 04/16/2009 | US20090099173 Pyridopyridazine compounds, compositions and methods of use |
| 04/16/2009 | US20090099172 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099170 Sirtuin modulating compounds |
| 04/16/2009 | US20090099168 HIV Integrase inhibitors |
| 04/16/2009 | US20090099164 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/16/2009 | US20090099161 Substituted Imidazoquinolines and Imidazonaphthyridines |
| 04/16/2009 | US20090099158 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| 04/16/2009 | US20090099157 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090098218 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2 |
| 04/16/2009 | US20090098189 Azaindoles as inhibitors of soluble adenylate cyclase |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701868A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | CA2701865A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
| 04/16/2009 | CA2700824A1 Heterocyclic compounds as crth2 receptor antagonists |
| 04/16/2009 | CA2700803A1 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2046791A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 04/15/2009 | EP2046789A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 04/15/2009 | EP2046788A1 Triazolopyridine derivatives as herbicides |
| 04/15/2009 | EP2046787A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 04/15/2009 | EP2046763A2 Aurora kinase inhibitors from an encoded small molecule library |
| 04/15/2009 | EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/15/2009 | EP1809630B1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 04/15/2009 | EP1747220B1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
| 04/15/2009 | EP1725235B1 Piperidine derivatives useful as ccr3 antagonists |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS |